Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

WATSON ANDRODERM SYSTEM

NFPA

PRODUCT USE

Testosterone transdermal system.

SYNONYMS

"testosterone transdermal patch"

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

Toxic to aquatic organisms, may cause long- term adverse effects in the aquatic
environment.

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Not normally a hazard due to the physical form of product. The material is a physical irritant to the gastrointestinal tract.  

EYE

  Not normally a hazard due to physical form of product.  

INHALED

  Not normally a hazard due to physical form of product.  

CHRONIC HEALTH EFFECTS

  Primary route of exposure is usually by skin contact.  High doses of androgens over prolonged periods may produce liver tumors and hasten growth of cancer of the prostate. In pregnant women, androgens may cause the development of male secondary sex characteristics of the female fetus.  Exposure to small quantities may induce hypersensitivity reactions characterized by acute bronchospasm, hives (urticaria), deep dermal wheals (angioneurotic edema), running nose (rhinitis) and blurred vision . Anaphylactic shock and skin rash (non-thrombocytopenic purpura) may occur. An individual may be predisposed to such anti-body mediated reaction if other chemical agents have caused prior sensitization (cross-sensitivity).